|
|
(One intermediate revision not shown) |
Line 1: |
Line 1: |
- | ==Molecular and Biochemical Genetics==
| + | qE5m7O Enjoyed every bit of your blog article.Thanks Again. Much obliged. |
- | | + | |
- | ===Objectives===
| + | |
- | *Important terms:
| + | |
- | **'''"Incomplete" dominance or "semi-dominant": homozygous individuals have a worse manifestation than heterozygous individuals (achondroplasia).'''
| + | |
- | **"Distinct disorder": consistent clinical and radiological findings.
| + | |
- | | + | |
- | | + | |
- | *Important concepts:
| + | |
- | **Types of mutations:
| + | |
- | ***Missense: changed amino acid
| + | |
- | ***Nonsense: introduced stop codon
| + | |
- | ***Neutral / silent: no amino acid change
| + | |
- | ***Polymorphisms are a population term; it means 1% of the pop has it; it does not infer whether it causes disease or not
| + | |
- | ***RNA splicing: gain or loss of splice site
| + | |
- | ***Regulation mutation: affects gene regulation
| + | |
- | ***Indels: gain or loss of one or more bases; leads to frameshift if not a multiple of 3
| + | |
- | ***Repeat expansion: repeated segment (usually 3 bases) expands as nucleotide copy / repair mechanisms get hung up
| + | |
- | **Haploinsufficiency:
| + | |
- | **Dominant-negative effect:
| + | |
- | | + | |
- | | + | |
- | *For individual diseases, know: clinical features, mode of inheritance, genes involved / gene defect, pathogenesis, treatment (sometimes)
| + | |
- | | + | |
- | ===Review your fundamentals===
| + | |
- | | + | |
- | ===Dominant Diseases===
| + | |
- | *Dominant disease are defined as those manifested when only one allele is mutated.
| + | |
- | **Recall that some diseases can be both dominant and negative because of allelic heterogeneity and locus heterogeneity.
| + | |
- | *There are multiple ways a single allele (not both copies) can cause disease:
| + | |
- | **''Qualitative effects'': the protein product gains a function.
| + | |
- | **''Quantitative effects'': the protein product is broken.
| + | |
- | **Combination of qualitative and quantitative.
| + | |
- | **Others
| + | |
- | *It is important to understand the disease pathogenesis in order to think wisely about treatment.
| + | |
- | | + | |
- | ====[[Achondroplasia]]====
| + | |
- | | + | |
- | ====[[Osteogenesis imperfecta]]====
| + | |
- | | + | |
- | ====[[Ehlers Danlos Syndrome]]====
| + | |
- | | + | |
- | ====[[Marfan syndrome]]====
| + | |
- | | + | |
- | ====[[Familial Hypercholesterolemia]]====
| + | |
- | | + | |
- | ===Recessive Diseases===
| + | |
- | *Requires two mutant alleles to show the phenotype or disease state.
| + | |
- | *Recall that a proband with a recessive disease usually has parents who are both carriers.
| + | |
- | **However, there are exceptions: uniparental disomy, skewed lyonization.
| + | |
- | *Recessive disorders usually result from a missing component of a pathway.
| + | |
- | **Phenotype usually results from the accumulation of a precursor / metabolite.
| + | |
- | | + | |
- | ====[[Homocysteinuria]]====
| + | |
- | | + | |
- | ====[[Cystic Fibrosis]]====
| + | |
- | | + | |
- | ====[[Hemochromatosis]]====
| + | |
- | | + | |
- | ====[[Alpha-1-Anti-Trypsin deficiency]]====
| + | |
- | | + | |
- | ====[[Phenylketonuria]]====
| + | |
- | | + | |
- | ====[[Tay-Sachs Disease]]====
| + | |
- | | + | |
- | ====[[Galactosemia]]====
| + | |
- | | + | |
- | ====[[Maple Syrup Urine Disease]]====
| + | |
- | | + | |
- | ====[[Biotinidase Deficiency]]====
| + | |
- | | + | |
- | ===X-linked Diseases===
| + | |
- | | + | |
- | ====[[Rett Syndrome]]====
| + | |
- | | + | |
- | ====[[Lesch-Nyhan syndrome]]====
| + | |
- | | + | |
- | ====[[Inherited Muscular Dystrophies]]====
| + | |
- | | + | |
- | ===Newborn Screening===
| + | |
- | *The following criteria for newborn screening assure that our screening has ''analytic validity'', ''clinical validity'', and ''clinical utility'':
| + | |
- | **The disorder must be '''well defined'''.
| + | |
- | **The disorder must be '''fairly high in population frequency''' (to justify the cost of newborn screening by the cost saved in care for the true-positives).
| + | |
- | **The disorder must be '''poorly clinically detected early in life (assymptomatic)''' (otherwise it is more cost effective to let physicians identify the disease at newborn checkups).
| + | |
- | **The disorder must be '''significant in morbidity / mortality if left untreated''' (otherwise we might start treating things that have little consequence).
| + | |
- | **The disorder must be '''treatable such that there is an improved condition''' (lest we start adding anxiety to insult).
| + | |
- | **The test must be '''rapid, inexpensive, specific AND sensitive over an entire population'''.
| + | |
- | **The test must be '''acceptable and cost-effective'''.
| + | |
- | **The test must be '''appropriately administered'''.
| + | |
- | | + | |
- | | + | |
- | *Newborn screening is required by law on all infants
| + | |
- | **A second test is required if the first screen is done prior to 48 hours
| + | |
- | | + | |
- | | + | |
- | *In Indiana we screen for:
| + | |
- | **Metabolic disorders:
| + | |
- | ***[[Phenylketonuria]]
| + | |
- | ***[[Galactosemia]]
| + | |
- | ***[[Maple Syrup Urine Disease]]
| + | |
- | ***[[Homocysteinuria]]
| + | |
- | ***[[Biotinidase Deficiency]]
| + | |
- | **Endocrine disorders:
| + | |
- | ***Hypothyroidism
| + | |
- | ***Congenital Adrenal Hyperplasia
| + | |
- | **Hemoglobinopathies:
| + | |
- | ***Sickle Cell Disease
| + | |
- | **[[Cystic Fibrosis]]
| + | |
- | *Using several methods: enzyme assays, radiommunoassays, electrophoresis, tandem mass spectrometry
| + | |
- | | + | |
- | ====Pitfalls of Screening====
| + | |
- | *False positives cause unecessary stress / anxiety and investigation / treatment.
| + | |
- | *False negatives cause false security.
| + | |
- | *Recalling the requirement that a screened disease must be "treatable" in some effective way, we see that prolonging the knowledge of a disease may be a form of harm if the disease cannot be treated.
| + | |
- | *Medical procedures initiated because of screen results may be uncomfortable and unnecessary.
| + | |
- | | + | |
- | ===General Molecular / Biochemical Pathogenesis Principles===
| + | |
- | *Dominant diseases usually result from:
| + | |
- | **Gain of abnormal function
| + | |
- | **Haploinsufficiency
| + | |
- | **Dominant-negative effects (think multi-subunit proteins)
| + | |
- | **Combinations of these reasons
| + | |
- | *Recall that dominant disease can be "incomplete" and thus have more severe phenotypes when presented as homozygous conditions.
| + | |
- | *Recessive diseases usually result from:
| + | |
- | **Loss of normal function
| + | |
- | *Heterozygotes of recessive diseases (carriers) usually have enough wild-type gene product to function properly
| + | |
qE5m7O Enjoyed every bit of your blog article.Thanks Again. Much obliged.